Ablation of ventricular fibrillation and tachycardia.
Catheter ablation therapy for ventricular tachycardia has evolved over the past 20 years to become the first-line therapy. This development has been facilitated by technology that has allowed better anatomic and electrophysiologic correlations. A better understanding of radiofrequency (RF) ablation has led to safer and more effective treatments, allowing it to become a potent diagnostic and therapeutic tool in clinical cardiac electrophysiology. As more knowledge is gained about the mechanisms of arrhythmias through RF ablations, and better mapping technology and more effective methods for energy delivery become available, catheter ablation will become relevant for an increasing number of arrhythmias. This article addresses advances and applications of RF ablation to the treatment of ventricular arrhythmias in a variety of heart diseases.
Bindra
Paveljit S
PS
Hospital of the University of Pennsylvania, 9th Floor Founders-Cardiology, 3400 Spruce Street, Philadelphia, PA 19104, USA.
Marchlinski
Francis E
FE
D009202:Cardiomyopathies / Q000601:surgery; D017115:Catheter Ablation; D003324:Coronary Artery Disease / Q000601:surgery; D006801:Humans; D017180:Tachycardia, Ventricular / Q000503:physiopathology / Q000601:surgery*; D013771:Tetralogy of Fallot / Q000601:surgery; D014693:Ventricular Fibrillation / Q000503:physiopathology / Q000601:surgery*